Wordt geladen...
Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer
Despite our deepening understanding of the mechanisms of resistance and intensive efforts to develop therapeutic solutions to combat resistance, de novo and acquired tamoxifen resistance remains a clinical challenge, and few effective regimens exist to treat tamoxifen-resistant breast cancer. The co...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3855007/ https://ncbi.nlm.nih.gov/pubmed/23734685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.13.63 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|